MRD / Regn No. : 20250000817 Date : 22/06/2026
Patient Name : Sashi Kanta Jain Age & Gender : 66 Yrs. / Female
Contact No. : 9425251778 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : DYSTHYROID ORBIOTPATHY (15/Oct/2010) | THYROTOXICOSIS - GRAVE’S DISEASE (15/Oct/2010) | TYPE 2 DM (15/Oct/2005) | AORTIC STENOSIS (15/Oct/2025) | OBESITY (15/Oct/2005) |
Subjective : TYPE 2 DM FOR 20 YEARS,THYROID DSYFUNCTION FOR 15 YEARS,DYSESTHESIAS
Objective : NO THYROMEGALY
Analysis : TYPE 2 DM,THYROTOXICOSIS,DYSTHYROID ORBITOPATHY,DYSLIPIDEMIA,TRAB CLOSE TO NAD,AORTIC STENOSIS,RECENT UTI,SGLT2I INDUCED GU ITCHING
Plan : GET FIBROSCAN AND REVIEW WITH RESULTS  
Salient Investigations : VITAMIN B12: 269 pg/mL | VITAMIN D (25 OH): 34.34 ng/mL | IRON: 49.79 mcg/dL | TIBC: 378.49 mcg/dL | HDL HIGH DENSITY LIPOPROTEIN: 49 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 85 mg/dL | TGL TRIGLYCERIDE: 95 mg/dL | TOTAL CHO/HDL RATIO: 3 | TOTAL CHOLESTEROL: 149 mg/dl | VLDL: 19.07 mg/dl | VITAMIN B12: 269 pg/mL | VITAMIN D (25 OH): 34.34 ng/mL | IRON: 49.79 mcg/dL | TIBC: 378.49 mcg/dL | HDL HIGH DENSITY LIPOPROTEIN: 49 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 85 mg/dL | TGL TRIGLYCERIDE: 95 mg/dL | TOTAL CHO/HDL RATIO: 3 | TOTAL CHOLESTEROL: 149 mg/dl | VLDL: 19.07 mg/dl | A\G RATIO: 1.19 g/dl | ALBUMIN (SERUM): 3.85 g/dL | ALKALINE PHOSPHOTASE: 94.69 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 19.98 U/L | GLOBULIN: 3.23 g/dl | INDIRECT BILIRUBIN: 0.34 | SGOT (AST): 17.87 U/L | SGPT (ALT): 7.25 IU/L | TOTAL BILIRUBIN: 0.44 mg/dL | TOTAL PROTEIN: 7.08 g/dl | BUN BLOOD UREA NITROGEN: 11.15 mg/dL | CREATININE: 0.64 mg/dL | UREA: 23.86 mg/dL | CALCIUM: 8.76 mg/DL | URIC ACID: 4.05 | RANDOM BLOOD SUGAR: 114.06 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.2 % | TOTAL T3: 124 | TOTAL T4: 9.84 mcg/dL | TSH : 1.06 mIU/L | EGFR EGLOMERULAR FILTRATION RATE: 99.34 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 99.34 mL/min/1.73m2 | HEMOGLOBIN: 12.1 g/dL | MCH: 26.2 pg | MCHC: 28 gm % | MCV: 93.5 fl | PCV: 43.2 % | PLATELETS: 204 thou cells/ ul | FIB4: 2.15 | RBC COUNT: 4.62 million/ul | TOTAL COUNT WBC: 7.64 Cells/cmm
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES
SQ 0-0-24 UNITS AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 TABLET SITAGLIPTIN 100 MG
JANUVIA 100 MG
Medicine For DIABETES
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
3 PIOGLITAZONE 15 MG
PIOZ 15 MG
1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE ANKLE EDEMA AND WORSENING OF HEART FAILURE REPORT IF THERE IS INCREASED SWELLING OR SHORTNESS OF BREATH
4 TABLET IMEGLIMIN SR 1000 MG
IMEGLYN SR
Medicine For GLUCOSE CONTROL
PO 1-0-1 BEFORE FOOD
TILL NEXT VISIT
5 TABLET PREGABALIN SR 75 MG
PREGALIN SR 75 MG
Medicine For NEUROPATHY
0-0-1 AT BEDTIME
1 MONTH
6 CAPSULE MULTIVITAMIN
RICONIA
Medicine For MULTIVITAMIN
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE YELLOW DISCOLORATION OF URINE
       
Refill : 0 / Substitution:    
Education : CHECK GLUCOSE EVERY 2 DAYS AND IF THE FASTING GLUCOSE IS CONSISTENTLY MORE THAN 90 INCREASE THE INSULIN BY 2 UNITS. THIS IS THE NEW DOSE. REPEAT THIS EVERY TWO DAYS UNTIL THE FASTING IS CONSISTENTLY LESS THAN 90
Next Visit : 29/Jun/2026
Tests Suggested For Next Visit : FIBROSCAN OF THE LIVER PLEASE REPORT CAP SCORE AND FIBROSIS SCORE
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: